Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theingi M Thway

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical and Biomedical Analysis|October 19, 2011
Model-based strategy for bioanalytical method comparison: measurement of a soluble ligand as a biomarkerTheingi M Thway, Jin Wang, Laura A Brunner, et al.
The AAPS Journal|January 21, 2016
Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic ProteinsSteven Kathman, Theingi M Thway, Lei Zhou, et al.
Clinical and Translational Science|February 26, 2025
Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaTheingi M Thway, Jagadeesh Aluri, Bojan Lalovic, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 20, 2009
Experimental and statistical approaches in method cross-validation to support pharmacokinetic decisionsTheingi M Thway, Mark Ma, Jean Lee, et al.
The AAPS Journal|September 13, 2019
Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product DevelopmentO N Obianom, Theingi M Thway, S J Schrieber, et al.
Circulation|September 24, 2004
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activationTheingi M Thway, Sergiy G Shlykov, Mary-Clare Day, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 25, 2021
Non-clinical similarity of biosimilar ABP 798 with rituximab reference productHelen J McBride, Shea Jassem, Vincent Chow, et al.
Bioanalysis|November 19, 2010
Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromoleculesTheingi M Thway, Chris R Macaraeg, Dominador Calamba, et al.
Journal of Pharmaceutical Sciences|November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic ProteinsYow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 20, 2010
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male ratsXiaodong Li, Kelly S Warmington, Qing-Tian Niu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical and Biomedical Analysis|October 19, 2011
Model-based strategy for bioanalytical method comparison: measurement of a soluble ligand as a biomarkerTheingi M Thway, Jin Wang, Laura A Brunner, et al.
The AAPS Journal|January 21, 2016
Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic ProteinsSteven Kathman, Theingi M Thway, Lei Zhou, et al.
Clinical and Translational Science|February 26, 2025
Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaTheingi M Thway, Jagadeesh Aluri, Bojan Lalovic, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 20, 2009
Experimental and statistical approaches in method cross-validation to support pharmacokinetic decisionsTheingi M Thway, Mark Ma, Jean Lee, et al.
The AAPS Journal|September 13, 2019
Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product DevelopmentO N Obianom, Theingi M Thway, S J Schrieber, et al.
Circulation|September 24, 2004
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activationTheingi M Thway, Sergiy G Shlykov, Mary-Clare Day, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 25, 2021
Non-clinical similarity of biosimilar ABP 798 with rituximab reference productHelen J McBride, Shea Jassem, Vincent Chow, et al.
Bioanalysis|November 19, 2010
Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromoleculesTheingi M Thway, Chris R Macaraeg, Dominador Calamba, et al.
Journal of Pharmaceutical Sciences|November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic ProteinsYow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 20, 2010
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male ratsXiaodong Li, Kelly S Warmington, Qing-Tian Niu, et al.
Pageof 2